| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |